Paris biotech using CRISPR-based biotherapeutics to edit bacteria inside the human microbiome.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
Latest round
Series A - €2,000,000
✓ verified by our desk
Open roles
Eligo Bioscience is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile